---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-000843"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:13:01.861057+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# X4 Pharmaceuticals posts updated corporate presentation on website; no specific details disclosed

## Summary
- Updated corporate presentation posted on January 8, 2024, in the Investors section of www.x4pharma.com.
- No financial or operational metrics, guidance, or material events provided in the filing.
- Presentation content not appended; investors must access directly from the company website.
- Filing is a Regulation FD disclosure; information is furnished, not filed.

## SEC filing metadata
- accession: 0001628280-24-000843
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024000843/0001628280-24-000843-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024000843/xfor-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-000843
- JSON: https://secwatch.observer/filing/0001628280-24-000843.json
- Plain text: https://secwatch.observer/filing/0001628280-24-000843.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.